Research Article
Inhibition of the Nrf2-TrxR Axis Sensitizes the Drug-Resistant Chronic Myelogenous Leukemia Cell Line K562/G01 to Imatinib Treatments
Table 4
The impacts of siRNA-mediated Nrf2 knockdown to the mRNA expressions of Nrf2 and TrxR in K562/G01 cells.
| ||||||||||||||||||||||||||||||||||||||||
, compared with the uninfected K562/G01 group or NC-GFP-LV-infected group; n = 3 for each group. |